Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

A 17-year-old boy with Temporal Triangular Alopecia successfully grew new hair after a hair restoration surgery using follicular unit transplantation.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

NIR light therapy may effectively treat eye diseases and improve brain function without side effects.

A preterm baby's toes were saved from damage by quickly removing a thread that was cutting off circulation.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Trichorrhexis invaginata can occur with tinea capitis, though it's rare.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib was effective in treating both early and late onset alopecia areata.

The ABHRS has outlined its goals for the next year.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.